Citation Impact
Citing Papers
ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model
2023 StandoutNobel
mRNA therapeutics in cancer immunotherapy
2021
Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickase
2016 StandoutNobel
Inflammation and Alzheimer's disease
2000 Standout
The genetics of haemochromatosis
1988
Ocular toxicity of systemic asthma and allergy treatments
2006
Alpha-1 antitrypsin and liver disease: mechanisms of injury and novel interventions
2014
Global Initiative for Chronic Obstructive Lung Disease
2002 Standout
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
2005 Standout
Hepatitis B and C viruses in the etiology of hepatocellular carcinoma; a study in Greece using third-generation assays
2000
Epidemiology of COPD
2009 Standout
Preparation and Characterization of Latent α1-Antitrypsin
1995
TFOS DEWS II Diagnostic Methodology report
2017 Standout
Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA
2002
Prevalence of Hemochromatosis among 11,065 Presumably Healthy Blood Donors
1988 Standout
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
Differential Recognition of α1-Antitrypsin-Elastase and α1-Antichymotrypsin-Cathepsin G Complexes by the Low Density Lipoprotein Receptor-related Protein
1995
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003
2004 Standout
Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
2023 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Asthma
2017 Standout
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
2004 Standout
Hepatitis C virus and hepatocellualr carcinoma
1994
The causal relation between human papillomavirus and cervical cancer
2002 Standout
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
Crystal structure of cleaved human α1-antichymotrypsin at 2.7 å resolution and its comparison with other serpins
1991 Nobel
Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity.
1991
Effect of Inhaled Glucocorticoids in Childhood on Adult Height
2012
Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
2009 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
2010 StandoutNobel
Genetics and respiratory disease bullet 2: Alpha1-antitrypsin deficiency, cirrhosis and emphysema
1998
Chronic urticaria
2000
What do dysfunctional serpins tell us about molecular mobility and disease?
1995
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
The ferritins: molecular properties, iron storage function and cellular regulation
1996 Standout
Alzheimer Aβ neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides
1996
The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months
2006 Standout
Disorders of Iron Metabolism
1999 Standout
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
2006 Standout
Syndecans, Heparan Sulfate Proteoglycans, Maintain the Proteolytic Balance of Acute Wound Fluids
1998
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
The clinical progress of mRNA vaccines and immunotherapies
2022
Pulmonary Function in Middle-aged Women with Heterozygous Deficiency of the Serine Protease Inhibitor Alpha 1 -Antichymotrypsin
1990
Do Inhaled Corticosteroids Inhibit Growth in Children?
2001
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Prevention of Polymerization of M and Z α 1 -Antitrypsin ( α 1 -AT) with Trimethylamine N -Oxide
2001
Proteolytic inactivation of alpha-1-anti-chymotrypsin. Sites of cleavage and generation of chemotactic activity.
1991
The Fibroblast Growth Factor signaling pathway
2015 Standout
Glycosaminoglycans and their proteoglycans: host‐associated molecular patterns for initiation and modulation of inflammation
2006 Standout
Serpin Structure, Mechanism, and Function
2002 Standout
The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities.
1996 Nobel
Platyspondylic lethal skeletal dysplasia, San Diego type, is caused by FGFR3 mutations
1999
[1] Role of free radicals and catalytic metal ions in human disease: An overview
1990 Standout
Heparin protects cathepsin G against inhibition by protein proteinase inhibitors.
1994
Hereditary and nutritional iron overload
1992
A gradient of childhood self-control predicts health, wealth, and public safety
2011 Standout
mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients
2021
British Guideline on the Management of Asthma
2008
Lung volumes and forced ventilatory flows
1993 Standout
Inactive conformation of the serpin α1-antichymotrypsin indicates two-stage insertion of the reactive loop: Implications for inhibitory function and conformational disease
2000
Cloning, expression, purification, and biological activity of recombinant native and variant human alpha 1-antichymotrypsins.
1990
Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses
2005 Standout
Proteolytic inactivation of alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases.
1992
A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism
1995
Lessons From Sudden Coronary Death
2000 Standout
Matrix Metalloproteinases: A Review
1993 Standout
Unique role of allergens and the epithelium in asthma
1998
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Works of Bertil Lindmark being referenced
Heterozygous α‐antichymotrypsin and PiZ (α1‐antitrypsin deficiency
1990
Hepatitis C in chronic liver disease: an epidemiological study based on 566 consecutive patients undergoing liver biopsy during a 10‐year period
1992
Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study
2005
Hepatocyte inclusions of δ1‐antichymotrypsin in a patient with partial deficiency of δ1‐antichymotrypsin and chronic liver disease
1990
Outcome of pregnancy in a randomized controlled study of patients with asthma exposed to budesonide
2005
Budesonide‐treated asthmatic adolescents attain target height: a population‐based follow‐up study from Sweden
2002
Asthma and heterozygous α1‐antichymotrypsin deficiency: a possible association
1990
Heterozygous α1‐antichymotrypsin deficiency may be associated with cold urticaria
1992
Adult height in women with childhood asthma – a population‐based study
2001
The molecular basis of α1-antichymotrypsin deficiency in a heterozygote with liver and lung disease
1993
The microheterogeneity of desialylated α1-antichymotrypsin: the occurrence of two amino-terminal isoforms, one lacking a His-Pro dipeptide
1989
Reduced height in Swedish men with asthma at the age of conscription for military service
2000
Familial α1‐Antichymotrypsin Deficiency
1986
A phase I study (E011-MEL) of a TriMix-based mRNA immunotherapy (ECI-006) in resected melanoma patients: Analysis of safety and immunogenicity.
2019
Regional Differences in the Idiopathic Hemochromatosis Gene Frequency in Sweden
1985
Lack of Association between Hemochromatosis and α‐Antitrypsin Deficiency
1986